Mechanistic studies indicate that it can regulate the PTEN/Akt/GSK-3β/β-catenin axis by down-regulating miR-25-3p expression, inhibit the Wnt/β-catenin signaling pathway, and exert anti-tumor effects (240). The gene discussed is AKT1; the disease is neoplasm.